Quest Diagnostics

DGX - Quest DiagnosticsDividends

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
7/8/2026
0,86
Quarterly
4/6/2026
0,86
Quarterly
1/13/2026
0,8
Quarterly
10/3/2025
0,8
Quarterly
7/7/2025
0,8
Quarterly
4/7/2025
0,8
Quarterly
1/14/2025
0,75
Quarterly
10/4/2024
0,75
Quarterly
7/8/2024
0,75
Quarterly
4/5/2024
0,75
Quarterly
1/16/2024
0,71
Quarterly
10/5/2023
0,71
Quarterly
7/10/2023
0,71
Quarterly
4/6/2023
0,71
Quarterly
1/17/2023
0,66
Quarterly
10/3/2022
0,66
Quarterly
1/6

The latest dividend from DGX was $0.86 per share (ex-dividend 7/8/2026). The dividend yield over the last 12 months is 1,4%. Over the last 12 months there were 4 distributions, totalling $3.32 per share.